Figures & data
Figure 1. Urinary neopterin before and after the infusion reaction. Urine samples were obtained before the start of therapy, after the infusion reaction with every voiding in the ICU, and then daily. Neopterin, an indicator of systemic immune activation, was determined as described earlier Citation[5]. Urinary neopterin concentrations are usually stable in cancer patients. Increased concentrations reflect immune activation or infections, while decreased urinary neopterin has been associated with tumor control Citation[5].
![Figure 1. Urinary neopterin before and after the infusion reaction. Urine samples were obtained before the start of therapy, after the infusion reaction with every voiding in the ICU, and then daily. Neopterin, an indicator of systemic immune activation, was determined as described earlier Citation[5]. Urinary neopterin concentrations are usually stable in cancer patients. Increased concentrations reflect immune activation or infections, while decreased urinary neopterin has been associated with tumor control Citation[5].](/cms/asset/934381d6-ef61-4a48-8932-f7af7e93751c/ionc_a_312486_f0001_b.gif)